In conclusion, this study—the first to demonstrate that pre-inoculation of IRES-mediated insulin-secreting cells on microcarriers lowers blood glucose in T1D diabetic mice—presents several significant findings: (i) It introduces a promoter-free protein expression system that does not interfere with the host’s gene expression. The gene discussed is INS; the disease is type 1 diabetes mellitus.